Trial Profile

A Stable Glucagon Analog Administered by a Bihormonal Closed Loop System; a Feasibility Study

Status: Withdrawn prior to enrolment

Phase of Trial: Phase II

Latest Information Update: 09 Jan 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Dasiglucagon (Primary) ; Glucagon
Indications Type 1 diabetes mellitus
Focus Pharmacokinetics
Acronyms STABLE-1

Most Recent Events

29 Dec 2023 Planned End Date changed from 30 Aug 2023 to 29 Dec 2023.
29 Dec 2023 Planned primary completion date changed from 30 Jul 2023 to 29 Dec 2023.
29 Dec 2023 Status changed from not yet recruiting to withdrawn prior to enrolment.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com